Ros Med Pharmacy Limited
Summary
Ros Med Pharmacy Limited was set up on Thursday the 29th of October 2009. Their current partial address is Roscommon, and the company status is Normal. The company's current directors have been the director of 12 other Irish companies between them. Ros Med Pharmacy Limited has 3 shareholders.
Credit Score
- Latest Credit Movement:
- Date of Last Movement:13/01/2024
- Latest Accounts Filed:13/12/2023
- Report Based On Accounts:31/01/2023
- Next Set of Accounts Due:19/10/2024
- Overdue:No
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Ros Med Pharmacy Limited
- Time in Business:15 Years
- Company Number:476893
- Company Size:Small Company
- Current Status:NORMAL
- Principal Activity: ? [52.31] Dispensing Chemists
- May Trade As:Ros Med Pharmacy Ltd
- Largest Company Shareholder:
- Registered Address:Golf Links Road,
Co. Roscommon, Roscommon, Ireland
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Judgments
Discover poor payment histories of any company by searching our Judgment Database, for court actions brought against a company for non-payment of a debt. Plus get free Judgment monitoring alerts on this company for the next 12 months. Judgments are available as part of the Credit Report.
Judgment Report:
Search all Registered Bad Debt Judgments for Co. Name matches.
€5
Documents
| Document | Pages | Effective | Received | Buy |
|---|---|---|---|---|
| Form C6 - Declaration of satisfaction of a charge | 3 | 26/06/2020 | 19/02/2024 | |
| FINANCIAL STATEMENT | 18 | 19/10/2023 | 13/12/2023 | |
| Form B1C - Annual Return General | 6 | 19/10/2023 | 13/12/2023 | |
| FINANCIAL STATEMENT | 16 | 19/10/2022 | 07/12/2022 | |
| Form B1C - Annual Return General | 6 | 19/10/2022 | 07/12/2022 | |
| AMENDED CONSTITUTION | 11 | 11/11/2016 | 12/11/2016 | |
| Migrated Certificate | 1 | 29/10/2009 | 27/10/2009 |